Matches in SemOpenAlex for { <https://semopenalex.org/work/W4212920865> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W4212920865 endingPage "361" @default.
- W4212920865 startingPage "361" @default.
- W4212920865 abstract "361 Background: Characteristics of patients with high risk for recurrence non-metastatic renal cell carcinoma (nmRCC) participating in adjuvant therapy clinical trials post-nephrectomy have not been well described. We evaluated high risk nmRCC patients in the CKCis database to explore differences between trial and non-trial patients. Methods: Adult patients undergoing partial or radical nephrectomy for clear cell nmRCC between January 1, 2011 and March 31, 2021 were included. CKCis is a prospective cohort of patients from 14 Canadian academic institutions. Patients with high risk nmRCC (using modified UCLA Integrated Staging System) were included. Demographic, clinical, and survival statistics were analyzed for all patients and comparatively for the trial and non-trial groups. Results: 1459 patients, including 63 in adjuvant trials, were evaluated. 71% were male, 91% had pT3N0M0 disease. Disease characteristics including tumor size, stage, grade, location, necrosis, and margin status were similar between groups. Trial patients were younger (mean age 58.1 vs. 63.6; p < 0.0001) and had lower Charlson Comorbidity Index scores (median 4 [3,6) vs. 5 [4,6] p < 0.001). Estimated overall survival (OS) at 5 years was 80.8% (95% CI, 65,90) for trial patients and 74.8% (95% CI, 71,78.2) for non-trial patients. Recurrence-free survival at 5 years for trial patients was 48.6% (95% CI, 34,61.7) and 39.2% (95% CI, 35.2,43.1) for non-trial patients. Conclusions: Patients in adjuvant trials were younger and healthier at baseline than the average high risk nmRCC CKCis patient. Trial patients appear to have had longer time to recurrence and longer survival compared to non-trial patients, although not reaching statistical significance. Selection bias is common in clinical trials and evaluation of real-world population-based evidence of patients receiving adjuvant therapy will be important to ensure phase 3 trial results have external validity." @default.
- W4212920865 created "2022-02-24" @default.
- W4212920865 creator A5005699907 @default.
- W4212920865 creator A5009043218 @default.
- W4212920865 creator A5013185325 @default.
- W4212920865 creator A5013233212 @default.
- W4212920865 creator A5022267545 @default.
- W4212920865 creator A5022449065 @default.
- W4212920865 creator A5027234568 @default.
- W4212920865 creator A5028194267 @default.
- W4212920865 creator A5028436511 @default.
- W4212920865 creator A5033181043 @default.
- W4212920865 creator A5037646183 @default.
- W4212920865 creator A5043219978 @default.
- W4212920865 creator A5048403085 @default.
- W4212920865 creator A5056525627 @default.
- W4212920865 creator A5064078958 @default.
- W4212920865 creator A5071086661 @default.
- W4212920865 creator A5076796781 @default.
- W4212920865 creator A5077514210 @default.
- W4212920865 creator A5079983507 @default.
- W4212920865 creator A5088388062 @default.
- W4212920865 date "2022-02-20" @default.
- W4212920865 modified "2023-10-17" @default.
- W4212920865 title "Comparison of patients with high-risk nonmetastatic clear cell renal carcinoma in adjuvant therapy trials versus nonclinical trial patients." @default.
- W4212920865 doi "https://doi.org/10.1200/jco.2022.40.6_suppl.361" @default.
- W4212920865 hasPublicationYear "2022" @default.
- W4212920865 type Work @default.
- W4212920865 citedByCount "0" @default.
- W4212920865 crossrefType "journal-article" @default.
- W4212920865 hasAuthorship W4212920865A5005699907 @default.
- W4212920865 hasAuthorship W4212920865A5009043218 @default.
- W4212920865 hasAuthorship W4212920865A5013185325 @default.
- W4212920865 hasAuthorship W4212920865A5013233212 @default.
- W4212920865 hasAuthorship W4212920865A5022267545 @default.
- W4212920865 hasAuthorship W4212920865A5022449065 @default.
- W4212920865 hasAuthorship W4212920865A5027234568 @default.
- W4212920865 hasAuthorship W4212920865A5028194267 @default.
- W4212920865 hasAuthorship W4212920865A5028436511 @default.
- W4212920865 hasAuthorship W4212920865A5033181043 @default.
- W4212920865 hasAuthorship W4212920865A5037646183 @default.
- W4212920865 hasAuthorship W4212920865A5043219978 @default.
- W4212920865 hasAuthorship W4212920865A5048403085 @default.
- W4212920865 hasAuthorship W4212920865A5056525627 @default.
- W4212920865 hasAuthorship W4212920865A5064078958 @default.
- W4212920865 hasAuthorship W4212920865A5071086661 @default.
- W4212920865 hasAuthorship W4212920865A5076796781 @default.
- W4212920865 hasAuthorship W4212920865A5077514210 @default.
- W4212920865 hasAuthorship W4212920865A5079983507 @default.
- W4212920865 hasAuthorship W4212920865A5088388062 @default.
- W4212920865 hasConcept C121608353 @default.
- W4212920865 hasConcept C126322002 @default.
- W4212920865 hasConcept C141071460 @default.
- W4212920865 hasConcept C168563851 @default.
- W4212920865 hasConcept C2777472916 @default.
- W4212920865 hasConcept C2777982462 @default.
- W4212920865 hasConcept C2780091579 @default.
- W4212920865 hasConcept C2780227381 @default.
- W4212920865 hasConcept C535046627 @default.
- W4212920865 hasConcept C71924100 @default.
- W4212920865 hasConcept C72563966 @default.
- W4212920865 hasConceptScore W4212920865C121608353 @default.
- W4212920865 hasConceptScore W4212920865C126322002 @default.
- W4212920865 hasConceptScore W4212920865C141071460 @default.
- W4212920865 hasConceptScore W4212920865C168563851 @default.
- W4212920865 hasConceptScore W4212920865C2777472916 @default.
- W4212920865 hasConceptScore W4212920865C2777982462 @default.
- W4212920865 hasConceptScore W4212920865C2780091579 @default.
- W4212920865 hasConceptScore W4212920865C2780227381 @default.
- W4212920865 hasConceptScore W4212920865C535046627 @default.
- W4212920865 hasConceptScore W4212920865C71924100 @default.
- W4212920865 hasConceptScore W4212920865C72563966 @default.
- W4212920865 hasIssue "6_suppl" @default.
- W4212920865 hasLocation W42129208651 @default.
- W4212920865 hasOpenAccess W4212920865 @default.
- W4212920865 hasPrimaryLocation W42129208651 @default.
- W4212920865 hasRelatedWork W2013425347 @default.
- W4212920865 hasRelatedWork W2018137790 @default.
- W4212920865 hasRelatedWork W2045737731 @default.
- W4212920865 hasRelatedWork W2142381505 @default.
- W4212920865 hasRelatedWork W2369218934 @default.
- W4212920865 hasRelatedWork W2406002349 @default.
- W4212920865 hasRelatedWork W2470660931 @default.
- W4212920865 hasRelatedWork W2603122774 @default.
- W4212920865 hasRelatedWork W4285078605 @default.
- W4212920865 hasRelatedWork W4295761198 @default.
- W4212920865 hasVolume "40" @default.
- W4212920865 isParatext "false" @default.
- W4212920865 isRetracted "false" @default.
- W4212920865 workType "article" @default.